Rating History for Oruka Therapeutics (ORKA) by Piper Sandler

More Stocks Rated by Piper Sandler | Latest Ratings for ORKA
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
6/2/2026 Yasmeen Rahimi Maintain Overweight
(N/A)		 180.00
(N/A)		  
 		   Details